Orthopediatrics Income Statement Research

KIDS Stock

USD 30.63 0.43 1.42%

Most accounts from Orthopediatrics Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Orthopediatrics Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Orthopediatrics Corp Valuation and Orthopediatrics Corp Correlation analysis.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

At this time, Orthopediatrics Corp's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Interest Expense is likely to drop slightly above 188.1 K in 2024.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.At this time, Orthopediatrics Corp's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Interest Expense is likely to drop slightly above 188.1 K in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	2.4M	198K	188.1K
Depreciation And Amortization	11.8M	11.3M	17.4M	18.3M

Interest Expense Depreciation And Amortization

Orthopediatrics Corp income statement Correlations

	Discontinued Operations	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other	Tax Provision	Non Recurring
Discontinued Operations		-0.57	0.15	-0.62	-0.75	-0.7	-0.75	-0.69	0.56	0.3	0.55	-0.72	0.33	-0.55	-0.72	0.37	-0.1	0.34	0.42	-0.8	0.99	-0.49	-0.56	-0.36	0.19	0.44
Depreciation And Amortization	-0.57		-0.58	0.99	0.86	0.86	0.85	0.87	-0.96	-0.48	-0.96	0.83	-0.62	0.97	0.86	-0.57	0.35	-0.47	-0.63	0.73	-0.54	0.88	0.91	0.86	-0.13	-0.81
Interest Expense	0.15	-0.58		-0.55	-0.29	-0.35	-0.27	-0.34	0.44	0.1	0.42	-0.3	0.04	-0.69	-0.27	0.09	-0.41	0.05	0.25	-0.03	0.09	-0.77	-0.4	-0.7	-0.22	0.44
Selling General Administrative	-0.62	0.99	-0.55		0.88	0.89	0.88	0.89	-0.97	-0.43	-0.96	0.87	-0.66	0.97	0.89	-0.52	0.4	-0.43	-0.67	0.76	-0.59	0.87	0.92	0.89	-0.21	-0.77
Selling And Marketing Expenses	-0.75	0.86	-0.29	0.88		0.99	1.0	0.99	-0.88	-0.35	-0.87	0.98	-0.6	0.8	0.99	-0.44	0.35	-0.36	-0.68	0.94	-0.75	0.69	0.94	0.69	-0.35	-0.72
Total Revenue	-0.7	0.86	-0.35	0.89	0.99		0.99	1.0	-0.87	-0.3	-0.87	0.98	-0.58	0.82	0.99	-0.39	0.41	-0.3	-0.68	0.91	-0.7	0.71	0.96	0.74	-0.36	-0.71
Gross Profit	-0.75	0.85	-0.27	0.88	1.0	0.99		0.99	-0.87	-0.29	-0.87	0.97	-0.6	0.78	1.0	-0.39	0.4	-0.3	-0.71	0.93	-0.74	0.67	0.95	0.7	-0.42	-0.72
Other Operating Expenses	-0.69	0.87	-0.34	0.89	0.99	1.0	0.99		-0.89	-0.33	-0.89	0.98	-0.61	0.81	0.99	-0.42	0.4	-0.33	-0.7	0.91	-0.68	0.71	0.97	0.74	-0.36	-0.72
Operating Income	0.56	-0.96	0.44	-0.97	-0.88	-0.87	-0.87	-0.89		0.54	1.0	-0.85	0.81	-0.89	-0.9	0.64	-0.29	0.51	0.74	-0.77	0.54	-0.78	-0.94	-0.81	0.24	0.73
Net Income From Continuing Ops	0.3	-0.48	0.1	-0.43	-0.35	-0.3	-0.29	-0.33	0.54		0.54	-0.34	0.53	-0.4	-0.33	0.99	0.63	0.99	0.07	-0.45	0.29	-0.37	-0.36	-0.09	-0.53	0.21
Ebit	0.55	-0.96	0.42	-0.96	-0.87	-0.87	-0.87	-0.89	1.0	0.54		-0.85	0.81	-0.89	-0.89	0.64	-0.29	0.52	0.75	-0.77	0.53	-0.78	-0.94	-0.8	0.24	0.73
Research Development	-0.72	0.83	-0.3	0.87	0.98	0.98	0.97	0.98	-0.85	-0.34	-0.85		-0.6	0.81	0.97	-0.42	0.35	-0.35	-0.62	0.93	-0.72	0.71	0.92	0.72	-0.32	-0.61
Ebitda	0.33	-0.62	0.04	-0.66	-0.6	-0.58	-0.6	-0.61	0.81	0.53	0.81	-0.6		-0.52	-0.65	0.65	-0.08	0.5	0.76	-0.56	0.32	-0.39	-0.67	-0.49	0.36	0.33
Cost Of Revenue	-0.55	0.97	-0.69	0.97	0.8	0.82	0.78	0.81	-0.89	-0.4	-0.89	0.81	-0.52		0.79	-0.46	0.42	-0.4	-0.53	0.64	-0.51	0.94	0.84	0.93	-0.06	-0.71
Total Operating Expenses	-0.72	0.86	-0.27	0.89	0.99	0.99	1.0	0.99	-0.9	-0.33	-0.89	0.97	-0.65	0.79		-0.44	0.38	-0.33	-0.73	0.93	-0.71	0.67	0.96	0.71	-0.41	-0.72
Income Before Tax	0.37	-0.57	0.09	-0.52	-0.44	-0.39	-0.39	-0.42	0.64	0.99	0.64	-0.42	0.65	-0.46	-0.44		0.54	0.97	0.21	-0.53	0.36	-0.4	-0.45	-0.18	-0.39	0.29
Total Other Income Expense Net	-0.1	0.35	-0.41	0.4	0.35	0.41	0.4	0.4	-0.29	0.63	-0.29	0.35	-0.08	0.42	0.38	0.54		0.65	-0.54	0.11	-0.09	0.4	0.42	0.69	-0.7	-0.42
Net Income	0.34	-0.47	0.05	-0.43	-0.36	-0.3	-0.3	-0.33	0.51	0.99	0.52	-0.35	0.5	-0.4	-0.33	0.97	0.65		0.01	-0.48	0.33	-0.34	-0.33	-0.08	-0.53	0.19
Income Tax Expense	0.42	-0.63	0.25	-0.67	-0.68	-0.68	-0.71	-0.7	0.74	0.07	0.75	-0.62	0.76	-0.53	-0.73	0.21	-0.54	0.01		-0.52	0.41	-0.47	-0.74	-0.6	0.68	0.61
Interest Income	-0.8	0.73	-0.03	0.76	0.94	0.91	0.93	0.91	-0.77	-0.45	-0.77	0.93	-0.56	0.64	0.93	-0.53	0.11	-0.48	-0.52		-0.8	0.52	0.83	0.48	-0.27	-0.58
Extraordinary Items	0.99	-0.54	0.09	-0.59	-0.75	-0.7	-0.74	-0.68	0.54	0.29	0.53	-0.72	0.32	-0.51	-0.71	0.36	-0.09	0.33	0.41	-0.8		-0.46	-0.55	-0.33	0.21	0.42
Net Interest Income	-0.49	0.88	-0.77	0.87	0.69	0.71	0.67	0.71	-0.78	-0.37	-0.78	0.71	-0.39	0.94	0.67	-0.4	0.4	-0.34	-0.47	0.52	-0.46		0.72	0.86	0.08	-0.67
Reconciled Depreciation	-0.56	0.91	-0.4	0.92	0.94	0.96	0.95	0.97	-0.94	-0.36	-0.94	0.92	-0.67	0.84	0.96	-0.45	0.42	-0.33	-0.74	0.83	-0.55	0.72		0.79	-0.37	-0.78
Non Operating Income Net Other	-0.36	0.86	-0.7	0.89	0.69	0.74	0.7	0.74	-0.81	-0.09	-0.8	0.72	-0.49	0.93	0.71	-0.18	0.69	-0.08	-0.6	0.48	-0.33	0.86	0.79		-0.3	-0.63
Tax Provision	0.19	-0.13	-0.22	-0.21	-0.35	-0.36	-0.42	-0.36	0.24	-0.53	0.24	-0.32	0.36	-0.06	-0.41	-0.39	-0.7	-0.53	0.68	-0.27	0.21	0.08	-0.37	-0.3		0.22
Non Recurring	0.44	-0.81	0.44	-0.77	-0.72	-0.71	-0.72	-0.72	0.73	0.21	0.73	-0.61	0.33	-0.71	-0.72	0.29	-0.42	0.19	0.61	-0.58	0.42	-0.67	-0.78	-0.63	0.22

Click cells to compare fundamentals

Orthopediatrics Corp Account Relationship Matchups

Orthopediatrics Corp income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	3.5M	3.4M	2.2M	2.4M	198K	188.1K
Total Revenue	72.6M	71.1M	98.0M	122.3M	148.7M	77.9M
Gross Profit	54.6M	55.0M	73.4M	90.7M	93.9M	56.0M
Operating Income	(9.1M)	(20.4M)	(17.9M)	(21.8M)	(25.8M)	(24.5M)
Ebit	(9.1M)	(20.4M)	(17.9M)	(21.8M)	(25.8M)	(24.5M)
Research Development	5.7M	5.3M	5.5M	8.0M	10.2M	5.3M
Ebitda	(4.5M)	(12.4M)	(6.1M)	(10.5M)	(8.4M)	(8.8M)
Cost Of Revenue	17.9M	16.0M	24.6M	31.6M	54.9M	57.6M
Income Before Tax	(12.7M)	(33.7M)	(17.4M)	(3.7M)	(21.3M)	(22.4M)
Net Income	(17.2M)	(32.9M)	(16.3M)	1.3M	(21.0M)	(22.0M)
Income Tax Expense	4.5M	(723K)	(1.1M)	(4.9M)	(338K)	(321.1K)
Net Interest Income	(3.5M)	(3.4M)	(2.2M)	(2.4M)	(44K)	(46.2K)

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orthopediatrics Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orthopediatrics Corp's short interest history, or implied volatility extrapolated from Orthopediatrics Corp options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Orthopediatrics Corp is a strong investment it is important to analyze Orthopediatrics Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orthopediatrics Corp's future performance. For an informed investment choice regarding Orthopediatrics Stock, refer to the following important reports:

How To Invest In Orthopediatrics

Details

Is Orthopediatrics Stock a good investment?

Details

What is Orthopediatrics Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Orthopediatrics Corp Valuation and Orthopediatrics Corp Correlation analysis.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Orthopediatrics Stock analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

6.559

Quarterly Revenue Growth

0.214

Return On Assets

(0.04)

Return On Equity

(0.06)

The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Orthopediatrics Income Statement Research

Orthopediatrics Corp income statement Correlations

Orthopediatrics Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Orthopediatrics Corp income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Orthopediatrics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Selling And Marketing Expenses
Other Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Gross Profit
Ebit	+ 1.0	Operating Income
Extraordinary Items	+ 0.99	Discontinued Operations
Selling General Administrative	+ 0.99	Depreciation And Amortization

Operating Income	- 0.97	Selling General Administrative
Ebit	- 0.96	Selling General Administrative
Ebit	- 0.96	Depreciation And Amortization
Operating Income	- 0.96	Depreciation And Amortization
Reconciled Depreciation	- 0.94	Ebit
Reconciled Depreciation	- 0.94	Operating Income